AstraZeneca offers a rare, secular growth profile in biopharma, underpinned by a diversified commercial asset base and layered patent expirations. AZN faces a minor patent cliff, with most key ...
Almost four years after penning its first amyloidosis collaboration with Neurimmune, AstraZeneca has returned to pick up a second asset. The latest licensing deal involves NI009, a preclinical ...
Mon, December 8, 2025 Published on Dec. 7, 2025 Published on 2025-12-07T14:04:36+07:00 rugmaker AstraZeneca plans to launch 20 new medicines by 2030, half of which will focus on treating cancer, the ...
Less than two years after buying Chinese biotech Gracell for its cell therapy platform, AstraZeneca has reported encouraging clinical results with the lead CAR-T from the deal, GC012F (now AZD0120), ...
The pharmaceutical company AstraZeneca can move forward with an addition to one of the buildings on its Frederick campus, after getting approval from the city of Frederick’s Planning Commission. The ...
Details are trickling in about the new manufacturing facility pharmaceutical giant AstraZeneca is building in Albemarle County.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback